Breast cancer in Brazil: Present status and future goals

The Lancet Oncology

Volumn 13, Issue 3, 2012, Pages

  Lee, Brittany L ^a   Liedke, Pedro E R ^a,c   Barrios, Carlos H ^b,c,d   Simon, Sergio D ^c,e   Finkelstein, Dianne M ^a   Goss, Paul E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Grupo Brasileiro de Estudos Do Câncer de Mama GBECAM   (Brazil)

^d Grupo Latino Americano de Investigación Clínica en Oncologia GLICO   (Brazil)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUOROURACIL; METHOTREXATE; TAMOXIFEN; TAXANE DERIVATIVE;

BRAZIL; BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; DATA BASE; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ETHNICITY; GEOGRAPHY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; LOWEST INCOME GROUP; MAMMOGRAPHY; MASTECTOMY; MEDICAL LITERATURE; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS; SOUTH AND CENTRAL AMERICA;

AGED; ANTINEOPLASTIC AGENTS; BRAZIL; BREAST NEOPLASMS; DELIVERY OF HEALTH CARE, INTEGRATED; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MASTECTOMY; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY; RESIDENCE CHARACTERISTICS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 84863159814     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70323-0     Document Type: Review

References (79)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM Cancer incidence and mortality worldwide: IARC CancerBase no. 10. GLOBOCAN 2008 2010, International Agency for Research on Cancer, Lyon, France.
2. Breast cancer: prevention and control WHO, (accessed July 1, 2011). http://www.who.int/cancer/detection/breastcancer/en.
3. 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases WHO, (accessed July 1, 2011). http://who.int/nmh/Actionplan-PC-NCD-2008.pdf.
4. Beaglehole R, Ebrahim S, Reddy S, Voûte J, Leeder S Prevention of chronic diseases: a call to action. Lancet 2007, 370:2152-2157. the Chronic Disease Action Group.
5. Gaziano TA, Galea G, Reddy KS Scaling up interventions for chronic disease prevention: the evidence. Lancet 2007, 370:1939-1946.
6. Porter P "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med 2008, 358:213-216.
7. The global burden of disease: 2004 update 2008, WHO, World Health Organization, Geneva.
8. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008, 9:730-756. the CONCORD Working Group.
9. Ferlay J, Parkin DM, Steliarova-Foucher E Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46:765-781.
10. Estimativa 2010: Incidência de câncer no Brasil 2009, Instituto Nacional de Câncer, Ministério da Saúde, Rio de Janeiro.
11. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus. Lancet Oncol 2010, 12:387-398.
12. Pesquisa Nacional por Amostra De Domicílios. 2009: população residente, por cor ou raça, situação e sexo Instituto Brasileiro de Geografia e Estatística, (accessed July 1, 2011). http://www.sidra.ibge.gov.br/pnad/pnadpb.asp?o=3&i=P.
13. Reel M In Amazonia, defending the hidden tribes. July 8, 2007. Washington Post Foreign Service (accessed July 1, 2011). http://www.washingtonpost.com/wp-dyn/content/article/2007/07/07/AR2007070701312.html.
14. World development indicators The World Bank, (accessed Sept 13, 2011). http://data.worldbank.org/indicator.
15. Country comparison: distribution of family income-Gini index World Factbook CIA, (accessed Sept 13, 2011). https://www.cia.gov/library/publications/the-world-factbook/rankorder/2172rank.html.
16. Brazil health systems and services profile: monitoring and analysis of health systems change/reform, 2008 2011, Pan American Health Organization/WHO, Pan American Health Organization/World Health Organization, Brasilia.
17. Política nacional de atenção oncológica Rede Câncer, (accessed April 1, 2011). http://www.redecancer.org.br/wps/wcm/connect/apoiogestao/site/home.
18. World Bank health nutrition and population statistics database The World Bank, (accessed April 11, 2011). http://data.worldbank.org/data-catalog/health-nutrition-and-population-statistics.
19. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 2010, 11:165-173.
20. O'Neill J Building better global economics. Nov 30, 2001. Global economics paper no: 66. Goldman Sachs Global Economics Website (accessed July 1, 2011). http://www2.goldmansachs.com/ideas/brics/building-better-doc.pdf.
21. Barreto ML, Teixeira MG, Bastos FI, Ximenes RA, Barata RB, Rodrigues LC Successes and failures in the control of infectious diseases in Brazil: social and environmental context, policies, interventions, and research needs. Lancet 2011, 377:1877-1889.
22. 2010 population census: age pyramid Instituto Brasileiro de Geografia e Estatistíca, (accessed July 1, 2011). http://www.ibge.gov.br/english/estatistica/populacao/censo2010/default.shtm.
23. Atlas de mortalidade por cancer: taxas de mortalidade das 5 localizações primárias mais frequentes, ajustadas por idade, pela população mundial, por 100·000 mulheres, Brasil, entre 1979 e 2006 Instituto Nacional de Câncer, Ministério da SaúdeMinistério da Saúde, (accessed July 1, 2011). http://mortalidade.inca.gov.br.
24. Altekruse SF, Kosary CL, Krapcho M, et al. SEER cancer statistics review 1975-2007 2011, National Cancer Institute, Bethesda, MD.
25. Yip CH, Smith RA, Anderson BO, et al. Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer 2008, 113(suppl):2244-2256. the Breast Health Global Initiative Early Detection Panel.
26. Fonseca LA, Eluf-Neto J, Wunsch Filho V Trends of cancer mortality in Brazilian state capitals, 1980. Rev Assoc Med Bras 2004, 56:309-312.
27. Simon SD, Bines J, Barrios CH, et al. Clinical characteristics and outcome of treatment of Brazilian women with breast cancer treated at public and private institutions-the AMAZONE project of the Brazilian breast cancer study group (GBECAM). San Antonio Breast Cancer Symposium 2009; San Antonio, TX, USA; Dec 11, 2009. Abstr 3082.
28. Controle do câncer de mama: documento de consenso 2004, Instituto Nacional de Câncer, Ministério da Saúde, Rio de Janiero, Brazil.
29. Press release Ministério da Saúde, (accessed June 22, 2011). http://portal.saude.gov.br/portal/aplicacoes/noticias/default.cfm?pg=dspDetalheNoticia&id_area=124&CO_NOTICIA=12810.
30. 2010 Population Census Instituto Brasileiro de Geografia e Estatística, (accessed Sept 20, 2011). http://www.ibge.gov.br/english/estatistica/populacao/censo2010/default.shtm.
31. Lima-Costa MF, Matos DL Prevalence and factors associated with mammograms in the 50-69-year age group: a study based on the Brazilian National Household Sample Survey (PNAD-2003). Cad Saude Publica 2007, 23:1665-1673.
32. Marchi AA, Gurgel MS Adherence to the opportunistic mammography screening in public and private health systems. Rev Bras Ginecol Obstet 2010, 32:191-197.
33. Marinho LA, Cecatti JG, Osis MJ, Gurgel MS Knowledge, attitude and practice of mammography among women users of public health services. Rev Saude Publica 2008, 42:200-207.
34. Passman LJ, Farias AM, Tomazelli JG, et al. SISMAMA-implementation of an information system for breast cancer early detection programs in Brazil. Breast 2011, 20(suppl 2):S35-S39.
35. DATASUS - Departamento de Informática do SUS Ministério da Saúde, (accessed Sept 13, 2011). http://www2.datasus.gov.br/DATASUS/index.php?area=0202&VObj=http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sia/cnv/qa.
36. Health at a glance in 2010. OECD EU Edition. Chapter 3: health care resources, services and outcomes 2010, Health Data OECD, Organisation for Economic Co-operation and Development, Paris, France.
37. Health, United States, 2009: with special feature on medical technology National Center for Health Statistics, (accessed July 1, 2011). http://www.cdc.gov/cancer/breast/statistics/screening.htm.
38. Cazap E, Buzaid A, Garbino C, et al. Breast cancer in Latin America: experts perceptions compared with medical care standards. Breast 2010, 19:50-54.
39. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 1999, 79:858-864.
40. Rezende MC, Koch HA, Figueiredo JA, Thuler LC Factors leading to delay in obtaining definitive diagnosis of suspicious lesions for breast cancer in a dedicated health unit in Rio de Janeiro. Rev Bras Ginecol Obstet 2009, 31:75-81.
41. Trufelli DC, Miranda VC, Santos MB, et al. Analysis of delays in diagnosis and treatment of breast cancer patients at a public hospital. Rev Assoc Med Bras 2008, 54:72-76.
42. Anderson BO, Yip CH, Smith RA, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 2008, 113(suppl):2221-2243.
43. Informação para o avanço das ações de controle do câncer de mama no Brasil 2010, Instituto Nacional de Câncer, Ministério da Saúde/Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
44. Nassar A Core needle biopsy versus fine needle aspiration biopsy in breast-a historical perspective and opportunities in the modern era. Diagn Cytopathol 2011, 39:380-388.
45. Salles MdeA, Sanches FS, Perez AA, Gobbi H Importance of a second opinion in breast surgical pathology and therapeutic implications. Rev Bras Ginecol Obstet 2008, 30:602-608.
46. Salles MdeA, Gouvea AP, Savi D, et al. Training and standardized criteria improve the diagnosis of premalignant breast lesions. Rev Bras Ginecol Obstet 2008, 30:550-555.
47. Wludarski SC, Lopes LF, Berto E, Silva TR, Carvalho FM, Weiss LM, Bacchi CE HER2 testing in breast carcinoma: very low concordance rate between reference and local laboratories in Brazil. Appl Immunohistochem Mol Morphol 2011, 19:112-118.
48. Kingsmore D, Hole D, Gillis C Why does specialist treatment of breast cancer improve survival? The role of surgical management. Br J Cancer 2004, 90:1920-1925.
49. Rutgers EJ Guidelines to assure quality in breast cancer surgery. Eur J Surg Oncol 2005, 31:568-576.
50. Freedman G, Fowble B, Hanlon A, et al. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 1999, 44:1005-1015.
51. Salminen E, Izewska J, Andreo P IAEA's role in the global management of cancer-focus on upgrading radiotherapy services. Acta Oncol 2005, 44:816-824.
52. Directory of radiotherapy centers by country and region International Atomic Energy Agency, (accessed March 10, 2011). http://www-naweb.iaea.org/nahu/dirac/query.asp.
53. International Data Base US Census Bureau, (accessed March 10, 2011). http://www.census.gov/ipc/www/idb/rank.php.
54. Diretrizes para o Atendimento Radioterápico no Brasil (accessed March 1, 2011). http://www.sbradioterapia.com.br/#wrap=documentos.php.
55. Dowsett M, Cuzick J, Ingle J, et al. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 2010, 28:509-518.
56. Fonseca M, Araújo GT, Saad ED Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil. Rev Assoc Med Bras 2009, 55:410-415.
57. Sasse AD, Sasse EC Cost-effectiveness analysis of adjuvant anastrozol in post-menopausal women with breast cancer. Rev Assoc Med Bras 2009, 55:535-540.
58. Wright M, Wood J, Lynch T, Clark D Mapping levels of palliative care development: a global view. J Pain Symptom Manage 2008, 35:469-485.
59. Torres Vigil I, Aday LA, De Lima L, Cleeland CS What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Symptom Manage 2007, 34:315-327.
60. Cazap E, Buzaid AC, Garbino C, et al. Breast cancer in Latin America: results of the Latin American and Caribbean Society of Medical Oncology/Breast Cancer Research Foundation expert survey. Cancer 2008, 113(suppl):2359-2365. the Latin American and Caribbean Society of Medical Oncology.
61. US National Institutes of Health. US National Library of Medicine. (accessed Nov 3, 2011). http://clinicaltrials.gov/ct2/search/advanced.
62. Burki T Alex's Lemonade. Lancet Oncol 2011, 12:331.
63. FEMAMA Federacao Brasileira de Apoio Instituicoes Filantropicas de Apoio a Saude da Mama, (accessed July 1, 2011). http://www.femama.org.br/novo.
64. Schwartsmann G Breast cancer in South America: challenges to improve early detection and medical management of a public health problem. J Clin Oncol 2001, 19(suppl):S118-S124.
65. Campbell D, Chui M Pharmerging shake-up: new imperatives in a redefined world. 2010. IMS Health Incorporated (accessed July 1, 2011). http://www.imshealth.com/pharmerging.
66. The pharmaceutical industry in figures European Federation of Pharmaceutical Industries and Associations, (accessed July 1, 2011). http://www.efpia.org/content/default.asp?PageID=608.
67. Ministério da Saúde Agência Nacional de Vigilância Sanitária, (accessed March 2, 2011). http://www.anvisa.gov.br/medicamentos/pesquisa/index.htm.
68. Hurley D Leveraging Latin assets in clinical trials. Good Clin Pract J 2006, 13:16-19.
69. Thuler LC, Freitas HG Evaluation of a community-based intervention to enhance breast cancer screening practices in Brazil. J Eval Clin Pract 2008, 14:1012-1017.
70. Autier P, Boniol M, Gavin A, Vatten LJ Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011, 343:d4411.
71. Gøtzsche PC, Nielsen M Screening for breast cancer with mammography. Cochrane Database Syst Rev 2009, 4. CD001877.
72. Clegg LX, Reichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009, 20:417-435.
73. Vargas RB, Ryan GW, Jackson CA, Rodriguez R, Freeman HP Characteristics of the original patient navigation programs to reduce disparities in the diagnosis and treatment of breast cancer. Cancer 2008, 113:426-433.
74. Bese NS, Munshi A, Budrukkar A, Elzawawy A, Perez CA Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer 2008, 113(suppl):2305-2314. the Breast Health Global Initiative Radiation Therapy Focus Group.
75. Frasson AL, Zerwes FP, Braga AP, Barbosa FS, Koch HA Intraoperative radiotherapy in the conventional linear accelerator room for early breast cancer treatment: an alternative choice in developing countries. J Exp Clin Cancer Res 2007, 26:379-384.
76. Barton MB, Frommer M, Shafiq J Role of radiotherapy in cancer control in low-income and middle-income countries. Lancet Oncol 2006, 7:584-595.
77. Martins SJ, Yamamoto CA Clinical and economic issues in adjuvant chemotherapy for HER-2 positive breast cancer. Rev Assoc Med Bras 2008, 54:494-499.
78. Telli ML, Hunt SA, Carlson RW, Guardino AE Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 2007, 25:3525-3533.
79. Bines J, Eniu A Effective but cost-prohibitive drugs in breast cancer treatment: a clinician's perspective. Cancer 2008, 113(suppl):2353-2358.